Navigation Links
New PLATO Sub-Analysis of CABG Patients Presented at ACC
Date:3/16/2010

on the discovery, development and commercialization of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of $32.8 billion in 2009. In the United States, AstraZeneca is a $14.8 billion healthcare business.

For more information about AstraZeneca in the US or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).

References:

(1)Held. Ticagrelor Versus Clopidogrel In Patients With Acute Coronary Syndromes Treated With Coronary Artery Bypass Surgery: Results from The Plato Trial. Presented at 59th Annual Scientific Session, March 16, 2010; Atlanta Georgia. ACC Abstract Number 10-A-9909-ACC.


'/>"/>
SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
2. Medco, Mayo Clinic Study Reveals Using a Simple Genetic Test Reduces Hospitalization Rates by Nearly a Third for Patients on Widely Prescribed Blood Thinner
3. Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
4. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
5. Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients
6. New Data Demonstrates Abbotts Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
7. An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists
8. Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
9. Chronically Ill Patients Find Help Paying For Medicines
10. ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
11. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 ApolloDx™ today announced it will ... a special event at the company,s office in ... 5, 2014. The event, which will start at 10:00 ... www.apollodx.com .    "We believe our ... Jared Bauer , Co-Founder and Managing Partner of ApolloDx. ...
(Date:8/20/2014)... DIEGO , Aug. 20, 2014 Trovagene, ... diagnostics, announced today that results from two clinical studies ... conference for the Company,s urine-based diagnostic test for the ... The IPV conference is scheduled to take place in ... to 25 th . Additionally, a new U.S. ...
(Date:8/20/2014)... August 20, 2014 Phase I ... the US  KalVista Pharmaceuticals ("KalVista"), an ophthalmology ... today announces that it has begun a Phase I, ... inhibitor, KVD001, for the treatment of DME. The study,s ... Beetham Eye Institute, Joslin Diabetes Center; Harvard Medical School ...
Breaking Medicine Technology:Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
... Therapies, Inc. (ITI),today announced it has initiated a ... its drug candidate ITI-722. ITI-722 acts predominantly,as a ... new,approach to the treatment of SMI. Because of ... activities, ITI believes, ITI-722 can be,used not only ...
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), an ... it has retained Financial,Relations Board (FRB), as its ... promising HIV-1/AIDS vaccine human trial results need to ... catastrophic AIDS,pandemic," stated Kathy Waller, co-president of FRB., ...
Cached Medicine Technology:Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 2Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 3Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 4GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 2GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 3GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 4
(Date:8/20/2014)... 2014 Top10BestSEOHosting.com is a website ... hosting products. It is headed by a team ... site offers research-based information and factual studies about ... the current market. , Recently, Top10BestSEOHosting.com has ... GoDaddy and Bluehost are the most ...
(Date:8/20/2014)... 2014 Today, Zane Benefits, the ... of a new eBook, Affordable Care Act 101. ... owners feel uncertain about how the ACA impacts ... bottom line. , The new eBook outlines key ... navigate their upcoming health insurance decisions. , Read ...
(Date:8/20/2014)... Aug. 19, 2014 (HealthDay News) -- A group representing ... get a flu shot. According to the American ... in recent years have upheld the safety and effectiveness ... is highly infectious and can be particularly dangerous to ... and other complications," Dr. Laura Riley, chair of the ...
(Date:8/20/2014)... Less than 42 percent of women underwent breast ... factors associated with foregoing reconstruction included being black, ... , Author: Monica Morrow, M.D., of the Memorial ... , Background: The Women,s Health and Cancer Rights ... reconstruction following a mastectomy. Still, most women who ...
(Date:8/20/2014)... Hundreds of Mirena IUD lawsuits ( ... were allegedly injured due to spontaneous migration of the ... County Superior Court, Bernstein Liebhard LLP reports. According to ... the Court has established procedures regarding the production of ... part of the proceeding’s initial disposition pool. (In Re: ...
Breaking Medicine News(10 mins):Health News:New Reviews For Linux Web Hosting Suppliers Announced By Top10BestSEOHosting.com 2Health News:All Pregnant Women Need Flu Shot: Ob/Gyn Group 2Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4
... important improvements in product purification ... ... of Wyeth (NYSE: WYE ), announced today that it,has received ... [Recombinant], Plasma/Albumin-Free), a,recombinant factor VIII product, for patients with hemophilia A ...
... Methodist Mansfield Medical,Center has opened a new ... number of people with sleep disorders. The new ... sleep apnea,insomnia, restless leg syndrome, narcolepsy, snoring, sleepwalking, ... are estimated to suffer from sleep disorders,according to ...
... The following is a,statement by Robert D. Foreman, President ... Council (KCC) supports the findings of the Centers for,Medicare ... report yesterday,made clear that the time for a modernized ... services is upon us. We,could not agree more., ...
... of,pregnant women, babies and toddlers up to age three have ... has received a $6,000,grant from the March of Dimes to ... 18,000 clients we serve each year., There have been ... population has increased and the demographics have changed.,Families are struggling ...
... EDITOR,S PICK: Deficiency in the protein MBL2 is linked ... fibrosis (CF), a hereditary disorder causing thick mucous production ... mortality rate primarily due to lung failure. Although it ... the disease, variations in other genes between individuals with ...
... hope to target versions current shot misses, but fall ... -- A U.S. Food and Drug Administration panel on Thursday ... year,s batch of flu vaccine, in an unusual move that ... vaccine. , Typically, only one or two strains are changed ...
Cached Medicine News:Health News:Wyeth's XYNTHA Approved by FDA for Treatment of Hemophilia A 2Health News:Wyeth's XYNTHA Approved by FDA for Treatment of Hemophilia A 3Health News:Wyeth's XYNTHA Approved by FDA for Treatment of Hemophilia A 4Health News:New Sleep Diagnostic Center Opens at Methodist Mansfield 2Health News:Statement by Robert D. Foreman, President of The Kidney Care Council, Regarding the HHS Report to Congress 'A Design for a Bundled End Stage Renal Disease Prospective Payment System' 2Health News:Healthy Start of Southwest Florida Receives Grant From March of Dimes to Assess Needs of Pregnant Women and Babies 2Health News:JCI table of contents: Feb. 21, 2008 2Health News:JCI table of contents: Feb. 21, 2008 3Health News:JCI table of contents: Feb. 21, 2008 4Health News:JCI table of contents: Feb. 21, 2008 5Health News:JCI table of contents: Feb. 21, 2008 6Health News:JCI table of contents: Feb. 21, 2008 7Health News:JCI table of contents: Feb. 21, 2008 8Health News:JCI table of contents: Feb. 21, 2008 9Health News:JCI table of contents: Feb. 21, 2008 10Health News:FDA Panel OKs 3 New Flu Strains for Next Year's Vaccine 2Health News:FDA Panel OKs 3 New Flu Strains for Next Year's Vaccine 3
Portex® Blue Line® cuffed endotracheal tubes come in a wide selection of sizes, each with a standard 15 mm ISO connector., ,Portex® Blue Line® endotracheal tubes are recognized world...
... oral. Marked with recommended tube size ... Graduated. Single use. For improved surgical ... the tube by incorporating a preformed ... anatomical situation at body temperature. AGT ...
... Ruschelit® PVC. Murphy eye-oral. High volume/low ... Oral Cuffed Single use. For improved ... of the tube by incorporating a ... cuff. Thermosensitive Ruschelit® PVC adapts to ...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. Murphy eye. High volume/low pressure cuff. Connector is permanently fixed into the tube. X-ray opaque. Graduated. Single use. Steri...
Medicine Products: